Niche Focus X-BODY Biosciences specializes in discovering novel biotherapeutic compounds through innovative DNA-tagged human antibody libraries, positioning them as a provider of cutting-edge antibody discovery solutions.
Growing Funding With a recent funding of $2.7 million, X-BODY has financial backing that supports ongoing research and potential expansion initiatives, indicating upcoming opportunities for collaborations or partnerships.
Market Positioning As a small biotech company with a highly specialized focus, X-BODY may benefit from strategic technology partnerships or custom research collaborations with larger firms or research institutions.
Early-Stage Revenue Current revenue is modest, up to $1 million, presenting opportunities for sales of research services, licensing deals, or collaborative projects to accelerate growth.
Competitive Landscape Positioned alongside similar biotech firms with specialized antibody discovery capabilities, X-BODY can align with advanced technology providers to enhance its research tools and expand its therapeutic development pipeline.
$10M$25M
$50M$100M
$10M$25M
$100M$250M
$10M$25M
$25M$50M
$10M$25M
$50M$100M
$25M$50M| X-BODY Biosciences Email Formats | Percentage |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
Biotechnology ResearchMassachusetts, United States2-10 Employees
X-BODY is a privately held biotechnology company focused on discovering novel biotherapeutic compounds. The company’s mission is to apply its innovative capabilities and remarkably diverse DNA-tagged human antibody library to the discovery of human antibodies against novel therapeutic targets.
Company Overview
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com